69 related articles for article (PubMed ID: 2395116)
1. Maintenance of morphine dependence by naloxone in acutely dependent mice.
Sofuoglu M; Sato J; Takemori AE
J Pharmacol Exp Ther; 1990 Sep; 254(3):841-6. PubMed ID: 2395116
[TBL] [Abstract][Full Text] [Related]
2. Naloxone produces protracted tolerance in mice treated with a single dose of morphine.
Sofuoglu M; Takemori AE
J Pharmacol Exp Ther; 1990 Sep; 254(3):836-40. PubMed ID: 2395115
[TBL] [Abstract][Full Text] [Related]
3. Involvement of delta 2 opioid receptors in acute dependence on morphine in mice.
Miyamoto Y; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1993 Jun; 265(3):1325-7. PubMed ID: 8389861
[TBL] [Abstract][Full Text] [Related]
4. Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.
Miyamoto Y; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1993 Mar; 264(3):1141-5. PubMed ID: 8383738
[TBL] [Abstract][Full Text] [Related]
5. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
7. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
8. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
Martin JR; Takemori AE
J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795
[TBL] [Abstract][Full Text] [Related]
9. Reinitiation of sensitivity to naloxone by a single narcotic injection in postaddicted mice.
Brase DA; Iwamoto ET; Loh HH; Way EL
J Pharmacol Exp Ther; 1976 May; 197(2):317-25. PubMed ID: 944771
[TBL] [Abstract][Full Text] [Related]
10. Effects of agmatine on tolerance to and substance dependence on morphine in mice.
Li J; Li X; Pei G; Qin BY
Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):232-8. PubMed ID: 10452098
[TBL] [Abstract][Full Text] [Related]
11. Morphine-induced supersensitivity to the effects of naloxone on luteinizing hormone secretion in the male rat.
Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
J Pharmacol Exp Ther; 1983 Apr; 225(1):35-41. PubMed ID: 6682144
[TBL] [Abstract][Full Text] [Related]
12. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
13. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
Belozertseva IV; Andreev BV
Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
[TBL] [Abstract][Full Text] [Related]
14. Effects of Papaver rhoeas extract on the expression and development of morphine-dependence in mice.
Pourmotabbed A; Rostamian B; Manouchehri G; Pirzadeh-Jahromi G; Sahraei H; Ghoshooni H; Zardooz H; Kamalnegad M
J Ethnopharmacol; 2004 Dec; 95(2-3):431-5. PubMed ID: 15507371
[TBL] [Abstract][Full Text] [Related]
15. Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.
Mamiya T; Matsumura T; Ukai M
Ann N Y Acad Sci; 2004 Oct; 1025():424-9. PubMed ID: 15542745
[TBL] [Abstract][Full Text] [Related]
16. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
Kreeger JS; Larson AA
J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
[TBL] [Abstract][Full Text] [Related]
17. Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.
Kamei J; Ohsawa M; Saitoh A; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
J Pharmacol Exp Ther; 1995 Aug; 274(2):700-6. PubMed ID: 7636731
[TBL] [Abstract][Full Text] [Related]
18. A cyclic somatostatin analog that precipitates withdrawal in morphine-dependent mice.
Shook JE; Pelton JT; Kazmierski W; Lemcke PK; Villar RG; Hruby VJ; Burks TF
NIDA Res Monogr; 1987; 76():295-301. PubMed ID: 2893981
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
[TBL] [Abstract][Full Text] [Related]
20. Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence.
Kalinichev M; Holtzman SG
J Pharmacol Exp Ther; 2003 Feb; 304(2):603-9. PubMed ID: 12538812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
